Glucagon-like peptide-1 side effects range from mild nausea to rare pancreatitis. Learn how GLP-1 drugs work, who is at risk, and when to call a doctor.
Glucagon-like peptide-1 side effects are mostly gastrointestinal and usually mild: nausea, vomiting, diarrhea, and constipation are the most commonly reported problems. They typically show up in the first few weeks of treatment or right after a dose increase, and many people find they ease with time. Rare but serious risks include pancreatitis, gallbladder disease, and bowel obstruction, which is why these medications are used under medical supervision.
What Are the Most Common Glucagon-Like Peptide-1 Side Effects?
Clinical trials and prescribing labels for semaglutide, liraglutide, dulaglutide, and tirzepatide report a similar pattern. Nausea is the most common complaint, and it is usually worst in the days right after a dose goes up.
- Nausea — reported by roughly 20% to 50% of people, depending on the drug and the dose
- Vomiting and diarrhea — common, especially during the first month
- Constipation — affects a surprisingly large share of users
- Abdominal pain, bloating, and sulfur burps
- Reduced appetite and early fullness
- Headache and fatigue
- Injection-site redness or bruising with injectable forms
Most of these settle within a few weeks. If they do not, a doctor can slow the dose schedule, switch to a different glucagon-like peptide-1 receptor agonist, or add a short-term medication for nausea.
What Does Glucagon-Like Peptide 1 Do in the Body?
Glucagon-like peptide-1 (GLP-1) is a hormone your gut releases after you eat. To understand what does glucagon-like peptide 1 do, think of it as a fullness signal: it slows the stomach from emptying, tells the brain you have had enough, and prompts the pancreas to release insulin when blood sugar rises.
Prescription glucagon-like peptide-1 drugs mimic that hormone at levels far higher and longer-lasting than the body produces on its own. The slowed stomach emptying that helps control appetite is also the main reason nausea and vomiting happen. In other words, the side effects and the benefits come from the same mechanism.
Common vs. Serious Side Effects
Most side effects are uncomfortable rather than dangerous. The table below separates everyday complaints from the ones that need urgent attention.
| Side effect | How common | What to do |
|---|---|---|
| Nausea | Very common (up to 1 in 2 users at higher doses) | Eat smaller, lower-fat meals; ask about a slower dose increase |
| Vomiting | Common | Sip fluids often; call your doctor if you cannot keep liquids down |
| Diarrhea | Common | Replace fluids and electrolytes; cut back on sugar alcohols |
| Constipation | Common | Increase fiber and water; ask about a stool softener |
| Injection-site reaction | Common | Rotate sites; redness usually clears in a few days |
| Pancreatitis | Rare | Stop the drug and seek urgent care for severe upper abdominal pain |
| Gallbladder disease | Uncommon | Report right-upper abdominal pain, fever, or jaundice |
| Bowel obstruction (ileus) | Rare | Seek emergency care for severe constipation, bloating, and vomiting |
| Low blood sugar | Mainly with insulin or sulfonylureas | Check blood sugar; your doctor may lower the other medication |
GLP-1 receptor agonists also carry a boxed warning about thyroid C-cell tumors seen in rodents. It is not known whether the same risk applies to humans, but these drugs are not recommended for people with a personal or family history of medullary thyroid cancer or MEN2 syndrome.
Who Is More Likely to Have Problems?
Some people should be monitored more closely or avoid this drug class altogether.
- Anyone with a history of pancreatitis or gallbladder disease
- People with gastroparesis or another slow-emptying stomach condition
- People with kidney disease, especially if dehydration from vomiting sets in
- People taking insulin or sulfonylureas, which raises the risk of low blood sugar
- People who are pregnant or planning to become pregnant
- People with a personal or family history of medullary thyroid cancer
The glucagon-like peptide-1 weight loss results that made these drugs famous come from appetite suppression, not from a fat-burning effect. That also means nausea often tracks with how strongly appetite is suppressed, so dose increases can bring both more weight loss and more stomach upset.
How to Reduce Side Effects
- Start low and go slow. Stay at each dose step for the full recommended period.
- Eat smaller meals and stop when you feel full.
- Cut back on fried, greasy, and very spicy foods.
- Stay hydrated by sipping fluids through the day instead of gulping large amounts.
- Limit alcohol, which can worsen nausea and dehydration.
- Ask your prescriber about anti-nausea medication if symptoms interfere with daily life.
- Rotate injection sites if you use a pen or syringe.
Tell your doctor about every medication and supplement you take. Some interactions change how these drugs behave or raise the chance of low blood sugar.
When to Call a Doctor
Contact a healthcare professional right away if you notice any of the following:
- Severe, persistent abdominal pain that may radiate to your back
- Vomiting that keeps you from holding down fluids for more than a day
- Signs of dehydration, such as dizziness, dark urine, or confusion
- Yellowing of the skin or eyes, or right-upper abdominal pain with fever
- No bowel movement for several days along with severe bloating
- Vision changes, especially in people with diabetic retinopathy
- Rash, swelling, or trouble breathing after a dose
If you are scheduled for surgery or anesthesia, tell the anesthesiologist you take a GLP-1 medication. Guidelines recommend holding some of these drugs before procedures because of the risk of food remaining in the stomach.
Are GLP-1 Supplements the Same as Prescription Drugs?
No. A glucagon-like peptide-1 supplement sold online is not the same product as an FDA-approved medication, and oral peptides are largely broken down in the digestive tract. There is no evidence that these supplements produce the same appetite effects, or the same side effects, as prescription therapy.
If you are considering an over-the-counter product marketed for weight loss, talk with a pharmacist or physician first. Prescription GLP-1 medications have been studied in large trials, and even those require ongoing medical monitoring.
Frequently Asked Questions
What is the most common side effect of GLP-1 medications?
Nausea is the most common side effect, reported by roughly 20% to 50% of people depending on the drug and dose. It is usually mild, tends to be worst right after a dose increase, and often fades within a few weeks. Vomiting, diarrhea, and constipation are also frequently reported.
How long do glucagon-like peptide-1 side effects last?
Most side effects appear within the first few days to weeks after starting or increasing a dose and ease within about 4 to 8 weeks. If symptoms continue or interfere with eating and drinking, a doctor can slow the dose schedule or change medications. Persistent vomiting or dehydration needs medical attention right away.
Can GLP-1 drugs cause pancreatitis or other serious problems?
Pancreatitis is rare, occurring in well under 1% of people in clinical trials, but the risk is higher for those with a history of the condition. Severe, persistent upper abdominal pain that radiates to the back is a reason to stop the drug and seek urgent care. Gallbladder disease and bowel obstruction are also rare but serious complications.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.